Pass the CBIC Infection Control CIC Questions and answers with ExamsMirror

The correct answer is C, "the device manufacturer's written instructions for use," as this is the factor that determines the appropriate cleaning and disinfection process for a particular surgical instrument. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of surgical instruments must follow the specific instructions provided by the device manufacturer to ensure safety and efficacy. These instructions account for the instrument’s material, design, and intended use, specifying the appropriate cleaning agents, disinfection methods, sterilization techniques, and contact times to prevent damage and ensure the elimination of pathogens (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This is also mandatedby regulatory standards, such as those from the Food and Drug Administration (FDA) and the Association for the Advancement of Medical Instrumentation (AAMI), which require adherence to manufacturer guidelines to maintain device integrity and patient safety.

Option A (all surgical instruments are cleaned and sterilized in the same manner) is incorrect because different instruments have unique characteristics (e.g., materials like stainless steel vs. delicate optics), necessitating tailored reprocessing methods rather than a one-size-fits-all approach. Option B (instruments contaminated with blood must be bleach cleaned first) is a misconception; while blood contamination requires thorough cleaning, bleach is not universally appropriate and may damage certain instruments unless specified by the manufacturer. Option D (the policies of the sterile processing department) may guide internal procedures but must be based on and subordinate to the manufacturer’s instructions to ensure compliance and effectiveness.

The emphasis on manufacturer instructions aligns with CBIC’s focus on evidence-based reprocessing practices to prevent healthcare-associated infections (HAIs) and protect patients (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). Deviating from these guidelines can lead to inadequate sterilization or instrument damage, increasing infection risks.

When an infection preventionist (IP) identifies an increase in primary bloodstream infections (BSIs) associated with peripheral intravenous (IV) catheter insertion, the initial step in outbreak investigation and process improvement is to stratify the data to identify potential sources or patterns of infection. According to the Certification Board of Infection Control and Epidemiology (CBIC), the "Surveillance and Epidemiologic Investigation" domain emphasizes the importance of systematically analyzing data to pinpoint contributing factors, such as location, technique, or equipment use, in healthcare-associated infections (HAIs). The question specifies poor technique as a suspected cause, and the first step should focus on contextual factors that could influence technique variability.

Option A, stratifying infections by the location of IV insertion (pre-hospital, Emergency Department, or in-patient unit), is the most logical first step. Different settings may involve varying levels of training, staffing, time pressure, or adherence to aseptic technique, all of which can impact infection rates. For example, pre-hospital settings (e.g., ambulance services) may have less controlled environments or less experienced personnel compared to in-patient units, potentially leading to technique inconsistencies. The CDC’s Guidelines for the Prevention of Intravascular Catheter-Related Infections (2017) recommend evaluating the context of catheter insertion as a critical initial step in investigating BSIs, making this a priority for the IP to identify where the issue is most prevalent.

Option B, stratifying by the type of dressing used (gauze, CHG impregnated sponge, or transparent), is important but should follow initial location-based analysis. Dressings play a role in maintaining catheter site integrity and preventing infection, but their impact is secondary to the insertion technique itself. Option C, stratifying by the site of insertion (hand, forearm, or antecubital fossa), is also relevant, as anatomical sites differ in infection risk (e.g., the hand may be more prone to contamination), but this is a more specific factor to explore after broader contextual data is assessed. Option D, stratifying by the type of skin preparation used (alcohol, CHG/alcohol, or iodophor), addresses antiseptic efficacy, which is a key component of technique. However, without first understanding where the insertions occur, it’s premature to focus on skin preparation alone, as technique issues may stem from systemic factors across locations.

The CBIC Practice Analysis (2022) supports a stepwise approach to HAI investigation, startingwith broad stratification (e.g., by location) to guide subsequent detailed analysis (e.g., technique-specific factors). This aligns with the CDC’s hierarchical approach to infection prevention, where contextual data collection precedes granular process evaluation. Therefore, the IP should first stratify by location to establish a baseline for further investigation.

The infection preventionist (IP) should start by comparingSSI ratesbetween theacute-care operating roomand thestand-alone surgery center. This direct comparison will help determine if there is a statistically significant difference in infection rates and guide further investigation.

Step-by-Step Justification:

Identify Trends:

Compare SSI ratesbetween the two locationsover a set period to identify patterns​.

Assess Contributing Factors:

Look at factors such aspatient population, antibiotic prophylaxis, surgical techniques, environmental controls, and adherence to infection prevention protocols​.

Validate Surveillance Data:

Ensure thatconsistent SSI surveillance methodologiesare used at both locations to avoid discrepancies​.

Why Other Options Are Incorrect:

A. Initiate prospective surveillance for SSIs in hysterectomies performed at the stand-alone surgery center:

Prospective surveillance is beneficial butdoes not immediately answer the surgeon’s concernabout existing infections.

B. Compare the most recent post-hysterectomy SSI surveillance data from the surgery center with those of the previous 12 months:

This approach only looks at trends at thesurgery centerwithout comparing it to theacute-care setting.

C. Initiate post-hysterectomy SSI surveillance in hysterectomy patients to verify accuracy of current surveillance methodology:

This step is secondary. Before initiatingnew surveillance, a direct comparison should be made using existing data.

CBIC Infection Control References:

APIC Text, "Surgical Site Infection Surveillance and Prevention Measures"​.

The standard way to reportventilator-associated pneumonia (VAP) ratesis:

A white paper with black text AI-generated content may be incorrect.

Why the Other Options Are Incorrect?

A. Ventilator-associated pneumonia rate of 2%– This does not use thecorrect denominator (ventilator days).

C. Postoperative pneumonia rate of 6% in SICU patients–Not relevant, as the data focuses onVAP, not postoperative pneumonia.

D. More information is needed regarding ventilator days per patient–The total ventilator days are already provided, so no additional data is required.

CBIC Infection Control Reference

APIC and NHSN recommend reporting VAP rates as cases per 1,000 ventilator days​.

Glove Contamination and SSI Risk:

Failure to change contaminated gloves increases the risk of surgical site infections (SSIs)​.

Double-gloving with an outer glove change reduces contamination.

Why Other Options Are Incorrect:

B. Alcohol-based hand rubs: Are FDA-approved alternatives to traditional scrubs and effective​.

C. Delayed antibiotics: Increases infection risk, but immediate correction reduces harm.

D. Airflow disruption: Can increase SSI risk, but glove contamination poses a more direct threat.

CBIC Infection Control References:

APIC-JCR Workbook, "Surgical Infection Prevention," Chapter 6​.

The correct answer is B, "Fishbone diagram," as this is the most appropriate quality tool for the team to use when determining what has contributed to the recent increase in catheter-associated urinary tract infections (CAUTIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the fishbone diagram, also known as an Ishikawa or cause-and-effect diagram, is a structured tool used to identify and categorize potential causes of a problem. In this case, the team needs to explore the root causes of the CAUTI increase, which could include factors such as improper catheter insertion techniques, inadequate maintenance, staff training gaps, or environmental issues (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.2 - Analyze surveillance data). The fishbone diagram organizes these causes into categories (e.g., people, process, equipment, environment), facilitating a comprehensive analysis and guiding further investigation or intervention.

Option A (gap analysis) is useful for comparing current performance against a desired standard or benchmark, but it is more suited for identifying deficiencies in existing processes rather thanuncovering the specific causes of a recent increase. Option C (plan, do, study, act [PDSA]) is a cyclical quality improvement methodology for testing and implementing changes, which would be relevant after identifying causes and designing interventions, not as the initial tool for root cause analysis. Option D (failure mode and effect analysis [FMEA]) is a proactive risk assessment tool used to predict and mitigate potential failures in a process before they occur, making it less applicable to analyzing an existing increase in CAUTIs.

The use of a fishbone diagram aligns with CBIC’s emphasis on using data-driven tools to investigate and address healthcare-associated infections (HAIs) like CAUTIs, supporting the team’s goal of pinpointing contributory factors (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.3 - Identify risk factors for healthcare-associated infections). This tool’s visual and collaborative nature also fosters team engagement, which is essential for effective problem-solving in infection prevention.

To determine the number of employees whoseroconverted(became infected) after aneedlestick exposure, we use the given data:

Total Needlestick Injuries:250

Needlestick Injuries Involving Bloodborne Pathogens:100

Seroconversion Rate:2%

Calculation:

A black text with black numbers AI-generated content may be incorrect.

Why Other Options Are Incorrect:

A. 1:Incorrect calculation;2% of 100 is 2, not 1.

C. 5:Overestimates the actual number of infections.

D. 10:Exceeds the calculated value based on given data.

CBIC Infection Control References:

APIC Text, "Occupational Exposure and Seroconversion Risks"​.

APIC Text, "Bloodborne Pathogens and Needlestick Injury Prevention"​

Incidence rate is a fundamental epidemiological measure used to quantify the frequency of new cases of a disease within a specified population over a defined time period. The Certification Board of Infection Control and Epidemiology (CBIC) supports the use of such metrics in the "Surveillance and Epidemiologic Investigation" domain, aligning with the Centers for Disease Control and Prevention (CDC) "Principles of Epidemiology in Public Health Practice" (3rd Edition, 2012). The formula provided, XY×K=Rate\frac{X}{Y} \times K = RateYX​×K=Rate, represents the standard incidence rate calculation, where KKK is a constant (e.g., 1,000 or 100,000) to express the rate perunit population, and the question asks what YYY represents among the given options.

In the incidence rate formula, XXX typically represents the number of new cases (or events) of the disease occurring during a specific period, and YYY represents the population at risk during that same period. The ratio XY\frac{X}{Y}YX​ yields the rate per unit of population, which is then multiplied by KKK to standardize the rate (e.g., cases per 1,000 persons). The CDC defines the denominator (YYY) as the population at risk, which includes individuals susceptible to the disease over the observation period. Option B ("Number of infected patients") might suggest XXX if it specified new cases, but as the denominator YYY, it is incorrect because incidence focuses on new cases relative to the at-risk population, not the total number of infected individuals (which could include prevalent cases). Option C ("Population at risk") correctly aligns with YYY, representing the base population over which the rate is calculated.

Option A, "Population served," is a broader term that might include the total population under care (e.g., in a healthcare facility), but it is not specific to those at risk for new infections, making it less precise. Option D, "Number of events," could align with XXX (new cases or events), but as the denominator YYY, it does not fit the formula’s structure. The CBIC Practice Analysis (2022) and CDC guidelines reinforce that the denominator in incidence rates is the population at risk, ensuring accurate measurement of new disease occurrence.

Carbapenem-resistant Enterobacterales (CRE) colonization is most commonly found in thegastrointestinal (GI) tract. Therefore, rectal or peri-rectal cultures are recommended foractive surveillance screening.

Why the Other Options Are Incorrect?

B. Nares or axillary cultures– CRE is not primarily found in thenasal or axillary region; this method is more relevant for detectingMRSA.

C. Abscess or blood cultures– While CRE may be present inclinical infections, these cultures are not used forscreening asymptomatic carriers.

D. Throat or nasopharyngeal cultures– CRE does not commonly colonize theupper respiratory tract, so these are not ideal for active screening.

CBIC Infection Control Reference

TheCDC and APIC guidelinesemphasizerectal or peri-rectal swabbingas the most effectiveactive surveillance methodfor CRE detection​.

The correct answer is C, "Ambulance personnel should be evaluated for possible exposure," as this statement is true regarding the need for evaluating exposure to communicable illness. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the presence of Gram negative diplococci in a cerebral spinal fluid (CSF) specimen is suggestive of a serious bacterial infection, most likely Neisseria meningitidis, which causes meningococcal disease. This condition is highly contagious and can be transmitted through respiratory droplets or direct contact with respiratory secretions, particularly during procedures like intubation (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.1 - Identify infectious disease processes). The patient was intubated during ambulance transport, creating a potential aerosol-generating procedure (AGP) that could have exposed ambulance personnel to infectious droplets before Droplet Precautions were instituted upon arrival at the Emergency Department (ED). Therefore, evaluating ambulance personnel for possible exposure is necessary to assess their risk and determine if post-exposure prophylaxis (e.g., antibiotics) or monitoring is required.

Option A (follow-up evaluation is not required for this laboratory finding) is incorrect because the identification of Gram negative diplococci in CSF is a critical finding that warrants investigation due to the potential for meningococcal disease, a reportable and transmissible condition. Option B (ED personnel should be evaluated for possible exposure) is less applicable since the patient was immediately placed in Droplet Precautions upon ED admission, minimizing exposure risk to ED staff after that point, though it could be considered if exposure occurred before precautions were fully implemented. Option D (follow-up evaluation is not necessary as the appropriate precautions were promptly instituted) is inaccurate because the prompt institution of Droplet Precautions in the ED does not retroactively address the exposure risk during ambulance transport, where precautions were not in place.

The focus on evaluating ambulance personnel aligns with CBIC’s emphasis on identifying and mitigating transmission risks associated with communicable diseases, particularly in high-risk settings like ambulance transport (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). This step is supported by CDC guidelines, which recommend exposure evaluation and prophylaxis for close contacts of meningococcal disease cases (CDC Meningococcal Disease Management, 2021).